Researchers at the University of California, Davis have developed smart, supramolecular, materials that can assemble into nanoparticles. These particles can then be used to target tumor cells.

Brief description not available

Brief description not available

This invention demonstrates that an engineered cellular reverse transcriptase is a potent motor protein that can processively thread single-stranded RNA (ssRNA) through the MspA biological nanopore in single nucleotide steps while it is synthesizing cDNA. Notably, this represents a first-ever achievement for threading of ssRNA through the engineered Mycobacterium smegmatis porin A (MspA) nanopore in discrete steps, and also for ssRNA sequencing with the MspA nanopore. The inventors constructed the “quadromer map” for ssRNA in the MspA nanopore, which is essentially a table that can convert measured nanopore ion current to RNA sequences, using ssRNAs of known sequences. In addition, the inventors discovered that the single-molecule kinetic rates of the reverse transcriptase are affected by the presence of stable RNA secondary structures. Monitoring this biophysical behavior can be used to determine RNA structures during nanopore sequencing.  Nanopore sequencing is a powerful third generation sequencing technology that offers advantages such as ultra-long read length and direct detection of chemically modified bases. One of the key components of developing a successful nanopore sequencer is identifying potent motor proteins (such as polymerases or helicases) that can thread single-stranded (ss) DNA or ssRNA through the nanopore in discrete steps with high processivity.   

Researchers at the University of California, Irvine have developed a guided electrokinetic assembly technique that utilizes dielectrophoretic and electroosmotic forces for micro- and nanomanufacturing. This technique provides a new way for assembling microelectronics and living cells for tissue engineering applications.

Researchers at the University of California, Davis have produced continuous, sheath-core, coaxial fibers with highly porous, nanocellulose, aerogel cores for use as high-performance insulators.

Researchers at the University of California, Davis have collaborated with colleagues at the University of Washington and Emory University to develop a DNA-based, memory and data storage technology that integrates seamlessly with semiconductor-based technologies and conventional electronic devices.

Researchers at the University of California, Riverside can discriminate between mixed populations of cells and particles in solution using pressure to displace objects across a nanopore multiple times.  Ionic current flow through the nanopore indicates the pressure required to translocate the object in the pore, which correlates to the object’s mass and volume.  Key to these results is that a nanopore sensor allows pressure oscillations to capture and release repeatedly the same object to learn about its inertia and morphology.  Such data can provide details about the size and shape of analytes, their morphologies and structural constraints, or even pathological conditions of living cells. Fig. 1 Nanopore sensing of differently sized cells in a mixed bacterial culture.  

Researchers at the University of California, Davis have developed RNA-based therapeutics to treat Wnt5A-expressing cancers, including treatment-resistant prostate cancer.

Prof. Juan Pablo Giraldo and his colleagues from the University of California, Riverside have developed a foliar formulation for increasing crop protection and photosynthetic performance when crops are under light, heat, and salinity stress. This is achieved by applying a nanomaterial (poly (acrylic acid) nanoceria, PNC) that interacts with plant chloroplasts to reduce abiotic stress. The nanoparticle formulation uses a novel, scalable and biocompatible approach to protect plant seeds, seedlings, and mature plants from stress.  The emerging field of nano-enabled agriculture has the potential to create crops that are protected from climate change induced stresses and have enhanced photosynthesis.   Fig 1: a, Nanoceria (PNC) increases photosynthesis and biomass in Arabidopsis plants under stress. No nanoparticles (NNP) are shown as control. b, Substantial damage to Arabidopsis plants exposed to excess light was mitigated by PNC.  

Researchers in the Department of Chemistry and Biochemistry at UCLA have developed a method for the production of crystalline, iridescent emulsions stable to repeated dilutions.

UCLA researchers in the Department of Mechanical Engineering have developed a method to manufacture zinc-based metal matrix nanocomposites (MMNCs) for functional applications, such as stents.

While some cell therapies have experienced success, many current cell therapies fall short in that enough cells do not reach the target tissue and/or the cells are incapable of producing clinically relevant thresholds of desired products sufficient to impact the disease state. Consequently, there is a major fundamental need to genetically engineer therapeutic cells to be more effective and robust using integrating viruses and powerful gene editing technologies like CRISPR, which can target ten to hundreds of genes simultaneously. However, this is highly problematic because the process of genetic engineering introduces dangerous unwanted mutations into the genome that can lead to cancer and other life-threatening diseases, especially if such cells permanently engraft into the body or fuse with host cells, which is common with stem cells. Therefore, the FDA does not readily permit the introduction of new genetic material or the extensive alteration of endogenous genes in cell-based therapies with the exception of CAR-T cells. For this reason, there is a major underlying need in the cell therapy sector to genetically enhance therapeutic cells to express gene products encoding biologics and then render them safe prior to clinical use.

Researchers at the University of California, Davis have developed a bioengineered, RNA-based treatment for advanced liver cancer and hepatocellular carcinoma (HCC).

Researchers at the University of California, Davis have developed a method of synthesizing stem cell-derived, exosome-mimicking, nanovesicles that have the therapeutic potential to rescue apoptotic neurons in culture.

The inventors have constructed conjugative plasmids for intra- and inter-species delivery and expression of RNA-guided CRISPR-Cas transposases for organism- and site-specific genome editing by targeted transposon insertion. This invention enables integration of large, customizable DNA segments (encoded within a transposon) into prokaryotic genomes at specific locations and with low rates of off-target integration.

UCLA researchers in the Department of Bioengineering have developed a novel electrically conductive scaffold system with a hyaluronic acid (HA)-based hydrogel for biomimetic research to treat spinal cord and other central nervous system (CNS) injuries.

UCLA researchers have developed a novel algorithm that can be used to design unique self-assembled molecules and nanostructures.

The inventors have developed an enzymatically catalyzed method for simple and rapid coupling of biomolecules to native amino acids on protein surfaces. This method is capable of attaching tyrosine or phenol containing molecules, peptides, or proteins to cystine or thiol containing targets at neutral pH with high yields. The inventors demonstrate the utility of this system by modifying Cas9 and other proteins with fluorophores, peptides, and whole proteins, such as green fluorescent proteins (GFPs) and antibody short chain variable fragments. This technology represents a novel paradigm in biomolecule coupling.

UCLA researchers in the department of Molecular and Medical Pharmacology have developed a novel capture system of circulating tumor cells for the early detection of metastatic cancer.

UCLA researchers in the department of Molecular and Medical Pharmacology have developed a novel matrix polymer capture system of circulating tumor cells that preserves biomolecular integrity through laser microdissection for the early detection of metastatic cancer.

Researchers at the University of California, Davis, in collaboration with researchers at IBM, have developed a widely applicable method to assemble molecules regardless of their intrinsic self-assembly properties.

UCLA researchers in the Department of Chemistry and Biochemistry have developed a novel method of reducing sizes of droplets in multiple emulsion systems.

UCLA researchers from the Department of Medicine have developed novel nanoparticle and imaging methods for the MRI-guided targeted delivery of therapeutic agents.

UCLA researchers in the Departments of Chemistry, Physics, and Bioengineering, led by Dr. Tim Deming of the Bioengineering Department, have developed new methods for adding different functional groups on polypeptides.  The UCLA researchers have used this method to create a platform to create and modify nanoscale vesicles and hydrogels for use in nanoscale drug delivery particles, injectable drug depots, imaging and detection, industrial biomaterials, and wound management.